EWA
Evolution Wealth Advisors Portfolio holdings
AUM
$683M
This Quarter Return
+3.11%
1 Year Return
+18.52%
3 Year Return
+65.11%
5 Year Return
+83.3%
10 Year Return
–
AUM
$231M
AUM Growth
+$231M
(+6.4%)
Cap. Flow
+$8.35M
Cap. Flow
% of AUM
3.61%
Top 10 Holdings %
Top 10 Hldgs %
74.73%
Holding
497
New
390
Increased
42
Reduced
20
Closed
28
Top Buys
| 1 |
Bank of America
BAC
|
$27.6M |
| 2 |
Freeport-McMoran
FCX
|
$10.3M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
$7.32M |
| 4 |
Alibaba
BABA
|
$4.72M |
| 5 |
Citigroup
C
|
$4.44M |
Top Sells
| 1 |
Vanguard Value ETF
VTV
|
$11.7M |
| 2 |
SPDR Gold Trust
GLD
|
$8.91M |
| 3 |
iShares MSCI Japan ETF
EWJ
|
$8.37M |
| 4 |
iShares TIPS Bond ETF
TIP
|
$7.04M |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
$5.75M |
Sector Composition
| 1 | Financials | 15.84% |
| 2 | Materials | 5.28% |
| 3 | Consumer Discretionary | 4.18% |
| 4 | Technology | 2.03% |
| 5 | Communication Services | 1.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRTX
126
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $21K | 0.01% |
+201
| New | +$21K |
|
127
McDonald's
MCD
$226B
| $20K | 0.01% |
+95
| New | +$20K |
|
128
Teladoc Health
TDOC
$1.37B
| $20K | 0.01% |
+308
| New | +$20K |
|
129
Teck Resources
TECK
$16.5B
| $20K | 0.01% |
+880
| New | +$20K |
|
130
Texas Instruments
TXN
$178B
| $20K | 0.01% |
+173
| New | +$20K |
|
131
Adobe
ADBE
$148B
| $19K | 0.01% |
+63
| New | +$19K |
|
132
Medtronic
MDT
$118B
| $19K | 0.01% |
+196
| New | +$19K |
|
133
Union Pacific
UNP
$132B
| $19K | 0.01% |
+110
| New | +$19K |
|
134
Jazz Pharmaceuticals
JAZZ
$7.99B
| $18K | 0.01% |
+125
| New | +$18K |
|
135
Coca-Cola
KO
$297B
| $18K | 0.01% |
+344
| New | +$18K |
|
136
Philip Morris
PM
$254B
| $18K | 0.01% |
+231
| New | +$18K |
|
137
PayPal
PYPL
$66.5B
| $18K | 0.01% |
161
-1,632
| -91% | -$182K |
|
138
Universal Health Services
UHS
$11.6B
| $18K | 0.01% |
+139
| New | +$18K |
|
139
AnaptysBio
ANAB
$630M
| $17K | 0.01% |
+301
| New | +$17K |
|
140
DaVita
DVA
$9.72B
| $17K | 0.01% |
+301
| New | +$17K |
|
141
IBM
IBM
$227B
| $17K | 0.01% |
+124
| New | +$17K |
|
142
Salesforce
CRM
$245B
| $16K | 0.01% |
104
-681
| -87% | -$105K |
|
143
Amicus Therapeutics
FOLD
$2.42B
| $16K | 0.01% |
+1,284
| New | +$16K |
|
|
AVP
144
DELISTED
Avon Products, Inc.
AVP
| $16K | 0.01% |
4,200
| – | – |
|
145
Coca-Cola Consolidated
COKE
$10.2B
| $15K | 0.01% |
+50
| New | +$15K |
|
146
Linde
LIN
$221B
| $15K | 0.01% |
+76
| New | +$15K |
|
147
Lockheed Martin
LMT
$105B
| $15K | 0.01% |
+42
| New | +$15K |
|
148
Regeneron Pharmaceuticals
REGN
$59.8B
| $15K | 0.01% |
+48
| New | +$15K |
|
149
RTX Corp
RTX
$212B
| $15K | 0.01% |
+112
| New | +$15K |
|
|
GBT
150
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $15K | 0.01% |
+279
| New | +$15K |
|